Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway.
Fan C, Li Y, Yang H, Cui Y, Wang H, Zhou H, Zhang J, Du B, Zhai Q, Wu D, Chen X, Guo H.
Fan C, et al. Among authors: zhai q.
J Mol Histol. 2019 Aug;50(4):343-354. doi: 10.1007/s10735-019-09831-1. Epub 2019 May 20.
J Mol Histol. 2019.
PMID: 31111288